AlloVir Statistics
Total Valuation
AlloVir has a market cap or net worth of $85.64 million. The enterprise value is -$37.10 million.
Market Cap | 85.64M |
Enterprise Value | -37.10M |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, before market open.
Earnings Date | Aug 1, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
AlloVir has 115.00 million shares outstanding. The number of shares has increased by 22.92% in one year.
Shares Outstanding | 115.00M |
Shares Change (YoY) | +22.92% |
Shares Change (QoQ) | +0.45% |
Owned by Insiders (%) | 49.42% |
Owned by Institutions (%) | 43.00% |
Float | 39.14M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.71 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.48, with a Debt / Equity ratio of 0.15.
Current Ratio | 18.48 |
Quick Ratio | n/a |
Debt / Equity | 0.15 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -104.00% and return on invested capital (ROIC) is -136.16%.
Return on Equity (ROE) | -104.00% |
Return on Assets (ROA) | -82.90% |
Return on Capital (ROIC) | -136.16% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.60M |
Employee Count | 112 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -126,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.10% in the last 52 weeks. The beta is 0.77, so AlloVir's price volatility has been lower than the market average.
Beta (5Y) | 0.77 |
52-Week Price Change | -78.10% |
50-Day Moving Average | 0.76 |
200-Day Moving Average | 1.04 |
Relative Strength Index (RSI) | 46.05 |
Average Volume (20 Days) | 594,977 |
Short Selling Information
The latest short interest is 6.05 million, so 5.26% of the outstanding shares have been sold short.
Short Interest | 6.05M |
Short Previous Month | 6.20M |
Short % of Shares Out | 5.26% |
Short % of Float | 15.46% |
Short Ratio (days to cover) | 11.20 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -188.97M |
Pretax Income | -179.66M |
Net Income | -179.53M |
EBITDA | -171.84M |
EBIT | -179.66M |
Earnings Per Share (EPS) | -$1.66 |
Balance Sheet
The company has $141.08 million in cash and $18.34 million in debt, giving a net cash position of $122.74 million or $1.07 per share.
Cash & Cash Equivalents | 141.08M |
Total Debt | 18.34M |
Net Cash | 122.74M |
Net Cash Per Share | $1.07 |
Equity (Book Value) | 120.44M |
Book Value Per Share | 1.05 |
Working Capital | 133.83M |
Cash Flow
Operating Cash Flow | -136.71M |
Capital Expenditures | n/a |
Free Cash Flow | -136.71M |
FCF Per Share | -$1.19 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
AlloVir does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.92% |
Shareholder Yield | -22.92% |
Earnings Yield | -209.63% |
FCF Yield | -159.63% |
Analyst Forecast
The average price target for AlloVir is $5.88, which is 689.58% higher than the current price. The consensus rating is "Hold".
Price Target | $5.88 |
Price Target Difference | 689.58% |
Analyst Consensus | Hold |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |